Acute GvHD | B | S.E. | p |
---|---|---|---|
Disease status | 0.92 | 0.47 | 0.053 |
Gender match | -0.29 | 0.50 | 0.56 |
Graft origin | 0.34 | 0.50 | 0.49 |
Conditioning | 0.055 | 0.60 | 0.93 |
Patient IL10 rs1800872 A/A | 1.30 | 0.60 | 0.031 |
Constant | -2.65 | 0.53 | |
Acute GvHD | B | S.E. | p |
Disease status | 1.26 | 0.53 | 0.017 |
Gender match | -0.32 | 0.50 | 0.53 |
Graft origin | 0.13 | 0.49 | 0.80 |
Conditioning | -0.11 | 0.61 | 0.85 |
Patient IL10Rβ rs28341676 A/A | 1.33 | 0.46 | 0.0041 |
Constant | -3.13 | 0.58 | |
Acute GvHD | B | S.E. | p |
Disease status | 1.26 | 0.53 | 0.017 |
Gender match | -0.39 | 0.56 | 0.49 |
Graft origin | 0.09 | 0.52 | 0.86 |
Conditioning | -0.52 | 0.67 | 0.44 |
IL-10 production level different and patient IL-10Rβ A/A | 2.16 | 0.49 | 0.0000088 |
Constant | -3.02 | 0.56 | |
Chronic GvHD | B | S.E. | p |
Disease status | 0.38 | 0.50 | 0.50 |
Gender match | -1.20 | 0.55 | 0.028 |
Graft origin | -1.58 | 0.48 | 0.0010 |
Conditioning | 1.10 | 0.65 | 0.087 |
aGvHD | 2.64 | 0.95 | 0.0052 |
IL-10 production level same and patient IL-10Rβ A/A | -1.18 | 0.50 | 0.017 |
Constant | 0.58 | 0.43 |